COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 25.16 |
| 52 Week High | 25.18 |
| 52 Week Low | 17.23 |
| Avg. Daily Vol. (Mil) | 12.06 |
| Beta (3 year) | 0.64 |
| Share Related Items | |
| Mkt Cap (Mil) | 49,841.46 |
| Shares Out (Mil) | 1,980.98 |
| Float (Mil) | 1,979.83 |
| Dividend Information | |
| Yield % | 4.90 |
| Annual Dividend | 1.24 |
| Payout Ratio | 81.00 |
| Financial Strength | |
| Quick Ratio | 1.40 |
| Current Ratio | 1.80 |
| LT Debt/ Equity | 0.43 |
| Total Debt / Equity | 0.45 |
| Valuation Ratios | |
| Price Earnings | 13.10 |
| Price/Sales | 2.36 |
| Price/Book | 3.43 |
| Price/Cash Flow | 9.20 |
| Per Share Data | |
| Earnings | 1.92 |
| Sales | 10.67 |
| Book Value | 7.33 |
| Cash Flow | 2.75 |
| Business Summary | |
|---|---|
| A global biopharmaceutical company, which through its divisions and subsidiaries, is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceutical and nutritional products. | |
| General Information | |
| 345 Park Avenue
New York, NY 10154 |
|
| www.bms.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 35000 | |
| CEO: James M. Cornelius | |
| Short Interest | |
| Current Month (Mil) | 20.05 |
| Previous Month (Mil) | 19.74 |
| Short Interest Ratio (Days) | 1.90 |
| Management Effectiveness | |
| Return on Equity | 32.70 |
| Return on Assets | 15.40 |
| Return on Investments | 22.80 |
| Profitability | |
| Gross Margin | 75.10 |
| EBIT Margin | 36.80 |
| Profit Margin | 22.50 |